Suzhou Xiaoli Pharmatech Co., Ltd.
Lab/Research institutions

地址:Suzhou China (Mainland) suzhou jiangsu

主营产品:Suzhou Xiaoli Pharmatech Co., Ltd.was established in 2017, which is a professional enterprise integrating research and development, manufacture and sales, engaged in catalysts, drug intermediates and functional silicone materials.

主要市场:North America South America Eastern Europe Southeast Asia Africa Western Europe n

业务范围:Suzhou Xiaoli Pharmatech Co., Ltd.was established in 2017, which is a professional enterprise integrating research and development, manufacture and sales, engaged in catalysts, drug intermediates and functional silicone materials.

注册资本: 1000000

公司规模:People

成立年份:2017

法人代表:Jin Yu

marvin.deng

0512-8781508815968883229

xmwang@xiaolitech.com marvin.deng@xiaolitech.com

www.xiaolipharma.com/index_en.html

Suzhou Xiaoli Pharmatech Co., Ltd.was established in 2017, which is a professional enterprise integrating research and development, manufacture and sales, engaged in catalysts, drug intermediates and functional silicone materials.

The company has an excellent and professional technical team in the field of new product development. Meanwhile, in order to meet the needs of customers, Xiaoli also have established a stable and win-win partnership with many domestic enterprises and research institutes.

With its business philosophy of "creating value, making profits and sharing prosperity", Xiaoli has gradually gained recognition and recognition from customers, relying on professional technical force, rich market experience and good business reputation. The company's production of 5-bromo-2-chlorobenzoic acid has an annual production capacity of 500 tons, and product quality has also been tested and certified by customers at home and abroad.

Practical working attitude, excellent product quality and professional after-sales service have established a good corporate image for Xiaoli.

We are committed to innovation and constantly challenge ourselves to meet our customers' higher demand for products and services.